{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:30:48Z","timestamp":1790613048598,"version":"4.1.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370890"],"award-info":[{"award-number":["82370890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["2019010668"],"award-info":[{"award-number":["2019010668"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH171"],"award-info":[{"award-number":["ZR2021MH171"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Higher Education Young Science and Technology Support Program","award":["2020KJL005"],"award-info":[{"award-number":["2020KJL005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02416-4","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T02:16:40Z","timestamp":1759371400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Review: Progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhaoqin","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"9255","key":"2416_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to virchow?? Lancet. 2001;357(9255):539\u201345.","journal-title":"Lancet"},{"issue":"7203","key":"2416_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"key":"2416_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pharmthera.2016.09.011","volume":"168","author":"KN Atretkhany","year":"2016","unstructured":"Atretkhany KN, Drutskaya MS, Nedospasov SA, Grivennikov SI, Kuprash DV. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment. Pharmacol Ther. 2016;168:98\u2013112.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"2416_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073\u201381.","journal-title":"Carcinogenesis"},{"issue":"2","key":"2416_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"7081","key":"2416_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan S, Weiss DS, Newton K, McBride J, O\u2019Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440(7081):228\u201332.","journal-title":"Nature"},{"issue":"3","key":"2416_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","volume":"24","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, et al. Critical role for NALP3\/CIAS1\/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006;24(3):317\u201327.","journal-title":"Immunity"},{"issue":"7081","key":"2416_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature04517","volume":"440","author":"TD Kanneganti","year":"2006","unstructured":"Kanneganti TD, Oz\u00f6ren N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3. Nature. 2006;440(7081):233\u20136.","journal-title":"Nature"},{"issue":"7081","key":"2416_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"8","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","volume":"14","author":"S Papin","year":"2007","unstructured":"Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of pyrin, mutated in Familial mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007;14(8):1457\u201366.","journal-title":"Cell Death Differ"},{"issue":"8","key":"2416_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"10","key":"2416_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med. 2009;15(10):1170\u20138.","journal-title":"Nat Med"},{"issue":"4","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","volume":"165","author":"VA Rathinam","year":"2016","unstructured":"Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell. 2016;165(4):792\u2013800.","journal-title":"Cell"},{"issue":"9","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. Nlrp3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. Nlrp3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139.","journal-title":"Nat Immunol"},{"issue":"1","key":"2416_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65.","journal-title":"Nat Rev Dis Primers"},{"issue":"10272","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Lancet"},{"issue":"9935","key":"2416_CR18","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"issue":"1","key":"2416_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.gastro.2011.03.044","volume":"141","author":"H Yang","year":"2011","unstructured":"Yang H, Li TW, Peng J, Tang X, Ko KS, Xia M, et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology. 2011;141(1):378\u201388. 88.e1-4.","journal-title":"Gastroenterology"},{"issue":"1","key":"2416_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95\u2013103.","journal-title":"J Hepatol"},{"key":"2416_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061745","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa H, Hayata Y, Yamada T, Kawamura S, Suzuki N, Koike K. Peribiliary glands as the cellular origin of biliary tract cancer. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19061745.","journal-title":"Int J Mol Sci"},{"key":"2416_CR22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202006194","author":"PI Seoane","year":"2020","unstructured":"Seoane PI, Lee B, Hoyle C, Yu S, Lopez-Castejon G, Lowe M, et al. The NLRP3-inflammasome as a sensor of organelle dysfunction. J Cell Biol. 2020. https:\/\/doi.org\/10.1083\/jcb.202006194.","journal-title":"J Cell Biol"},{"key":"2416_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022;236:108053.","journal-title":"Pharmacol Ther"},{"key":"2416_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276.","journal-title":"Front Immunol"},{"key":"2416_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081808","author":"AK Meyers","year":"2020","unstructured":"Meyers AK, Zhu X. The NLRP3 inflammasome: metabolic regulation and contribution to inflammaging. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9081808.","journal-title":"Cells"},{"issue":"5","key":"2416_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18(5):1141\u201360.","journal-title":"Cell Mol Immunol"},{"key":"2416_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2416_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","volume":"24","author":"J Fu","year":"2024","unstructured":"Fu J, Schroder K, Wu H. Mechanistic insights from inflammasome structures. Nat Rev Immunol. 2024;24(7):518\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2416_CR29","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41467-024-45396-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X, Matico RE, Miller R, Chauhan D, Van Schoubroeck B, Grauwen K, et al. Structural basis for the oligomerization-facilitated NLRP3 activation. Nat Commun. 2024;15(1):1164.","journal-title":"Nat Commun"},{"issue":"103","key":"2416_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adl2993","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Zhang L, Duan Y, Sun F, Odeh N, He Y, et al. NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D. Sci Immunol. 2025;10(103):eadl2993.","journal-title":"Sci Immunol"},{"issue":"10","key":"2416_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq4266","volume":"11","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Chen C, Liu C, Sun P, Liu P, Fang S, et al. Isocyanic acid-mediated NLRP3 carbamoylation reduces NLRP3-NEK7 interaction and limits inflammasome activation. Sci Adv. 2025;11(10):eadq4266.","journal-title":"Sci Adv"},{"issue":"1","key":"2416_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41590-022-01355-3","volume":"24","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Venditti R, Ran L, Liu Z, Vivot K, Sch\u00fcrmann A, et al. Distinct changes in endosomal composition promote NLRP3 inflammasome activation. Nat Immunol. 2023;24(1):30\u201341.","journal-title":"Nat Immunol"},{"issue":"26","key":"2416_CR33","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","volume":"184","author":"L Andreeva","year":"2021","unstructured":"Andreeva L, David L, Rawson S, Shen C, Pasricha T, Pelegrin P, et al. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell. 2021;184(26):6299\u2013e31222.","journal-title":"Cell"},{"issue":"7734","key":"2416_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","volume":"564","author":"J Chen","year":"2018","unstructured":"Chen J, Chen ZJ. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 2018;564(7734):71\u20136.","journal-title":"Nature"},{"issue":"7944","key":"2416_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2023","unstructured":"Xiao L, Magupalli VG, Wu H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature. 2023;613(7944):595\u2013600.","journal-title":"Nature"},{"issue":"1","key":"2416_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.immuni.2024.10.012","volume":"58","author":"BS Saller","year":"2025","unstructured":"Saller BS, W\u00f6hrle S, Fischer L, Dufossez C, Ingerl IL, Kessler S, et al. Acute suppression of mitochondrial ATP production prevents apoptosis and provides an essential signal for NLRP3 inflammasome activation. Immunity. 2025;58(1):90\u2013e10711.","journal-title":"Immunity"},{"issue":"84","key":"2416_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade7652","volume":"8","author":"SH Baik","year":"2023","unstructured":"Baik SH, Ramanujan VK, Becker C, Fett S, Underhill DM, Wolf AJ. Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. Sci Immunol. 2023;8(84):eade7652.","journal-title":"Sci Immunol"},{"issue":"1","key":"2416_CR38","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1038\/s41467-023-44203-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Luo L, Xu X, Wu J, Wang F, Lu Y, et al. Acetylation is required for full activation of the NLRP3 inflammasome. Nat Commun. 2023;14(1):8396.","journal-title":"Nat Commun"},{"issue":"17","key":"2416_CR39","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1016\/j.molcel.2024.08.001","volume":"84","author":"L Nie","year":"2024","unstructured":"Nie L, Fei C, Fan Y, Dang F, Zhao Z, Zhu T, et al. Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation. Mol Cell. 2024;84(17):3336\u2013e537.","journal-title":"Mol Cell"},{"issue":"2","key":"2416_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/15548627.2024.2395158","volume":"21","author":"S Yang","year":"2025","unstructured":"Yang S, Li M, Lian G, Wu Y, Cui J, Wang L. ABHD8 antagonizes inflammation by facilitating chaperone-mediated autophagy-mediated degradation of NLRP3. Autophagy. 2025;21(2):338\u201351.","journal-title":"Autophagy"},{"key":"2416_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406786","author":"J Jing","year":"2025","unstructured":"Jing J, Yang F, Wang K, Cui M, Kong N, Wang S, et al. UFMylation of NLRP3 prevents its autophagic degradation and facilitates inflammasome activation. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202406786.","journal-title":"Adv Sci"},{"issue":"8","key":"2416_CR42","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/2159-8290.CD-23-1300","volume":"14","author":"M Matusiak","year":"2024","unstructured":"Matusiak M, Hickey JW, van Lu IDGP, Kidzi\u0144ski G, Zhu L. Spatially segregated macrophage populations predict distinct outcomes in colon cancer. Cancer Discov. 2024;14(8):1418\u201339.","journal-title":"Cancer Discov"},{"issue":"12","key":"2416_CR43","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41423-019-0313-2","volume":"17","author":"J Chen","year":"2020","unstructured":"Chen J, Sun W, Zhang H, Ma J, Xu P, Yu Y, et al. Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1\u03b2. Cell Mol Immunol. 2020;17(12):1233\u201344.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"2416_CR44","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","volume":"54","author":"D Hofbauer","year":"2021","unstructured":"Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, B\u00fcttner-Herold M, Bach C, et al. \u03b2(2)-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity. 2021;54(8):1772\u2013e879.","journal-title":"Immunity"},{"issue":"10","key":"2416_CR45","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1080\/15548627.2020.1850609","volume":"17","author":"R Deng","year":"2021","unstructured":"Deng R, Zhang HL, Huang JH, Cai RZ, Wang Y, Chen YH, et al. MAPK1\/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. Autophagy. 2021;17(10):3011\u201329.","journal-title":"Autophagy"},{"key":"2416_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","volume":"497","author":"F Lu","year":"2021","unstructured":"Lu F, Zhao Y, Pang Y, Ji M, Sun Y, Wang H, et al. NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma. Cancer Lett. 2021;497:178\u201389.","journal-title":"Cancer Lett"},{"issue":"6","key":"2416_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1158\/0008-5472.CAN-23-1796","volume":"84","author":"M Mu","year":"2024","unstructured":"Mu M, Huang CX, Qu C, Li PL, Wu XN, Yao W, et al. Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy. Cancer Res. 2024;84(6):841\u201354.","journal-title":"Cancer Res"},{"key":"2416_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003069","author":"B Liu","year":"2022","unstructured":"Liu B, Zhou Z, Jin Y, Lu J, Feng D, Peng R, et al. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-003069.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"2416_CR49","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor cell-derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Res. 2020;80(5):1088\u2013101.","journal-title":"Cancer Res"},{"issue":"6","key":"2416_CR50","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","volume":"168","author":"D Yang","year":"2025","unstructured":"Yang D, Sun X, Wang H, Wistuba II, Wang H, Maitra A, et al. TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1\u03b2(+) macrophages. Gastroenterology. 2025;168(6):1153\u201369.","journal-title":"Gastroenterology"},{"issue":"6","key":"2416_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201903616","volume":"7","author":"Q Chen","year":"2020","unstructured":"Chen Q, Lei JH, Bao J, Wang H, Hao W, Li L, et al. BRCA1 deficiency impairs mitophagy and promotes inflammasome activation and mammary tumor metastasis. Adv Sci. 2020;7(6):1903616.","journal-title":"Adv Sci"},{"issue":"1","key":"2416_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15497-1","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, Osswald L, Saller BS, Unger S, De Feo D, Vinnakota JM, et al. Oncogenic Kras(G12D) causes myeloproliferation via NLRP3 inflammasome activation. Nat Commun. 2020;11(1):1659.","journal-title":"Nat Commun"},{"issue":"2","key":"2416_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41418-022-01095-9","volume":"30","author":"S Missiroli","year":"2023","unstructured":"Missiroli S, Perrone M, Gaf\u00e0 R, Nicoli F, Bonora M, Morciano G, et al. PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment. Cell Death Differ. 2023;30(2):429\u201341.","journal-title":"Cell Death Differ"},{"key":"2416_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004832","author":"HY Cheng","year":"2022","unstructured":"Cheng HY, Hsieh CH, Lin PH, Chen YT, Hsu DS, Tai SK, et al. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-004832.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"2416_CR55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.neo.2018.06.004","volume":"20","author":"CH Hsieh","year":"2018","unstructured":"Hsieh CH, Tai SK, Yang MH. Snail-overexpressing cancer cells promote M2-like polarization of tumor-associated macrophages by delivering miR-21-abundant exosomes. Neoplasia. 2018;20(8):775\u201388.","journal-title":"Neoplasia"},{"issue":"1","key":"2416_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-023-02834-7","volume":"42","author":"P Su","year":"2023","unstructured":"Su P, Mao X, Ma J, Huang L, Yu L, Tang S, et al. ERR\u03b1 promotes glycolytic metabolism and targets the NLRP3\/caspase-1\/GSDMD pathway to regulate pyroptosis in endometrial cancer. J Exp Clin Cancer Res. 2023;42(1):274.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2416_CR57","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41419-023-06096-1","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Yang Z, Zhu Y, Fu C, Li N, Peng F. Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma. Cell Death Dis. 2023;14(10):678.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2416_CR58","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan H, Wang Z, Teng D, Chen X, Zhu Z, Chen H, et al. Hexokinase 2 senses Fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metab. 2024;36(11):2449\u2013e676.","journal-title":"Cell Metab"},{"issue":"9","key":"2416_CR59","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, et al. Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res. 2021;9(9):1008\u201323.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2416_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02376-4","volume":"41","author":"L Xiao","year":"2022","unstructured":"Xiao L, Li X, Cao P, Fei W, Zhou H, Tang N, et al. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway. J Exp Clin Cancer Res. 2022;41(1):166.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2416_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111742","volume":"41","author":"AH Janneh","year":"2022","unstructured":"Janneh AH, Kassir MF, Atilgan FC, Lee HG, Sheridan M, Oleinik N, et al. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep. 2022;41(10):111742.","journal-title":"Cell Rep"},{"issue":"1","key":"2416_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40478-023-01646-2","volume":"11","author":"\u00c1 M\u00e9sz\u00e1ros","year":"2023","unstructured":"M\u00e9sz\u00e1ros \u00c1, Moln\u00e1r K, Fazakas C, N\u00f3gr\u00e1di B, L\u00fcvi A, Dud\u00e1s T, et al. Inflammasome activation in peritumoral astrocytes is a key player in breast cancer brain metastasis development. Acta Neuropathol Commun. 2023;11(1):155.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"2416_CR63","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s12276-024-01166-6","volume":"56","author":"S Magliacane Trotta","year":"2024","unstructured":"Magliacane Trotta S, Adinolfi A, D\u2019Orsi L, Panico S, Mercadante G, Mehlen P, et al. Cancer-derived exosomal Alu RNA promotes colorectal cancer progression. Exp Mol Med. 2024;56(3):700\u201310.","journal-title":"Exp Mol Med"},{"issue":"8","key":"2416_CR64","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-023-01047-4","volume":"20","author":"L Jing","year":"2023","unstructured":"Jing L, An Y, Cai T, Xiang J, Li B, Guo J, et al. A subpopulation of CD146(+) macrophages enhances antitumor immunity by activating the NLRP3 inflammasome. Cell Mol Immunol. 2023;20(8):908\u201323.","journal-title":"Cell Mol Immunol"},{"key":"2416_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc6998","author":"C Han","year":"2021","unstructured":"Han C, Godfrey V, Liu Z, Han Y, Liu L, Peng H, et al. The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation. Sci Immunol. 2021. https:\/\/doi.org\/10.1126\/sciimmunol.abc6998.","journal-title":"Sci Immunol"},{"issue":"15","key":"2416_CR66","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1016\/j.cell.2024.05.026","volume":"187","author":"D Zhivaki","year":"2024","unstructured":"Zhivaki D, Kennedy SN, Park J, Boriello F, Devant P, Cao A, et al. Correction of age-associated defects in dendritic cells enables CD4(+) T cells to eradicate tumors. Cell. 2024;187(15):3888\u2013e90318.","journal-title":"Cell"},{"issue":"7865","key":"2416_CR67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO, Tabaka M, Schramm MA, Xiao S, Tang R, Dionne D, et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature. 2021;595(7865):101\u20136.","journal-title":"Nature"},{"issue":"1","key":"2416_CR68","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41467-025-61324-w","volume":"16","author":"F Fan","year":"2025","unstructured":"Fan F, Wang J, Liu K, Zhang S, Gao J, Li X, et al. Mast cells boost anti-tumor potency of MAIT cells via inflammasome-dependent secretion of IL-18. Nat Commun. 2025;16(1):6074.","journal-title":"Nat Commun"},{"key":"2416_CR69","doi-asserted-by":"publisher","first-page":"628991","DOI":"10.3389\/fcell.2021.628991","volume":"9","author":"ZM Moghadam","year":"2021","unstructured":"Moghadam ZM, Henneke P, Kolter J. From flies to men: ROS and the NADPH oxidase in phagocytes. Front Cell Dev Biol. 2021;9:628991.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2416_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49549-7","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, Mao R, Yuan S, Xie Q, Meng J, Gu Y, et al. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nat Commun. 2024;15(1):5170.","journal-title":"Nat Commun"},{"issue":"1","key":"2416_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/07853890.2023.2166981","volume":"55","author":"Z He","year":"2023","unstructured":"He Z, Zhang J, Ma J, Zhao L, Jin X, Li H. R-spondin family biology and emerging linkages to cancer. Ann Med. 2023;55(1):428\u201346.","journal-title":"Ann Med"},{"key":"2416_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110528","volume":"200","author":"H Li","year":"2024","unstructured":"Li H, Zhang J, Yu B, Yang T, Liu B, Li F, et al. Rspo3 regulates the radioresistance of non-small cell lung cancer cells via NLRP3 inflammasome-mediated pyroptosis. Radiother Oncol. 2024;200:110528.","journal-title":"Radiother Oncol"},{"issue":"25","key":"2416_CR73","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, et al. IRE1\u03b1 silences DsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024;187(25):7248\u2013e6634.","journal-title":"Cell"},{"issue":"1","key":"2416_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-022-02291-8","volume":"41","author":"Z Li","year":"2022","unstructured":"Li Z, Fu WJ, Chen XQ, Wang S, Deng RS, Tang XP, et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to Temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022;41(1):74.","journal-title":"J Exp Clin Cancer Res"},{"key":"2416_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101054","volume":"73","author":"Y Kim","year":"2024","unstructured":"Kim Y, Jung KY, Kim YH, Xu P, Kang BE, Jo Y, et al. Inhibition of SIRT7 overcomes Sorafenib acquired resistance by suppressing ERK1\/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma. Drug Resist Updat. 2024;73:101054.","journal-title":"Drug Resist Updat"},{"issue":"12","key":"2416_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101329","volume":"4","author":"L Hurtado-Navarro","year":"2023","unstructured":"Hurtado-Navarro L, Cuenca-Zamora EJ, Zamora L, Bellosillo B, Such E, Soler-Espejo E, et al. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell Rep Med. 2023;4(12):101329.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2416_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07578-0","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu X, He H, Qi M, Jiang Z, Lin B, Wang X, et al. A small molecule directly targets NLRP3 to promote inflammasome activation and antitumor immunity. Cell Death Dis. 2025;16(1):252.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2416_CR78","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41565-024-01758-3","volume":"19","author":"M Tan","year":"2024","unstructured":"Tan M, Cao G, Wang R, Cheng L, Huang W, Yin Y, et al. Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade. Nat Nanotechnol. 2024;19(12):1903\u201313.","journal-title":"Nat Nanotechnol"},{"key":"2416_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122533","volume":"307","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Chen P, Hu B, Zhong S, Yan K, Wu Y, et al. MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes. Biomaterials. 2024;307:122533.","journal-title":"Biomaterials"},{"key":"2416_CR80","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jconrel.2023.10.017","volume":"363","author":"X Fu","year":"2023","unstructured":"Fu X, Li J, Wu Y, Mao C, Jiang Y. PAR2 deficiency tunes inflammatory microenvironment to magnify STING signalling for mitigating cancer metastasis via anionic CRISPR\/Cas9 nanoparticles. J Control Release. 2023;363:733\u201346.","journal-title":"J Control Release"},{"key":"2416_CR81","doi-asserted-by":"publisher","first-page":"155157","DOI":"10.1016\/j.phymed.2023.155157","volume":"123","author":"SR Mishra","year":"2024","unstructured":"Mishra SR, Behera BP, Singh VK, Mahapatra KK, Mundkinajeddu D, Bhat D, et al. Anticancer activity of Bacopa monnieri through apoptosis induction and mitophagy-dependent NLRP3 inflammasome inhibition in oral squamous cell carcinoma. Phytomedicine. 2024;123:155157.","journal-title":"Phytomedicine"},{"key":"2416_CR82","doi-asserted-by":"publisher","first-page":"154249","DOI":"10.1016\/j.phymed.2022.154249","volume":"103","author":"B Dai","year":"2022","unstructured":"Dai B, Fan M, Huang X, Gong Z, Cao H, Hu Y, et al. Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-\u03baB signaling in hepatocellular carcinoma cells. Phytomedicine. 2022;103:154249.","journal-title":"Phytomedicine"},{"issue":"22","key":"2416_CR83","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1158\/0008-5472.CAN-24-0220","volume":"84","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Pang L, Ding T, Chen K, Liu J, Wu M, et al. Precise in situ delivery of a photo-enhanceable inflammasome-activating nanovaccine activates anticancer immunity. Cancer Res. 2024;84(22):3834\u201347.","journal-title":"Cancer Res"},{"issue":"1","key":"2416_CR84","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12951-023-02231-4","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Yang J, Zhu N, Qiu H, Feng W, Chen Y, et al. Tumor-targeting hydroxyapatite nanoparticles for remodeling tumor immune microenvironment (TIME) by activating mitoDNA-pyroptosis pathway in cancer. J Nanobiotechnol. 2023;21(1):470.","journal-title":"J Nanobiotechnol"},{"key":"2416_CR85","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jconrel.2025.02.059","volume":"380","author":"C Li","year":"2025","unstructured":"Li C, Zhang N, Xu Z, Rong Z, Song C, Zhang Y, et al. Inflammasome mediated in situ cancer vaccine activated by Schottky heterojunction for augmented immunotherapy. J Control Release. 2025;380:1184\u201397.","journal-title":"J Control Release"},{"issue":"7","key":"2416_CR86","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1021\/acs.jmedchem.3c00175","volume":"66","author":"V Albanese","year":"2023","unstructured":"Albanese V, Missiroli S, Perrone M, Fabbri M, Boncompagni C, Pacifico S, et al. Novel aryl sulfonamide derivatives as NLRP3 inflammasome inhibitors for the potential treatment of cancer. J Med Chem. 2023;66(7):5223\u201341.","journal-title":"J Med Chem"},{"issue":"21","key":"2416_CR87","doi-asserted-by":"publisher","first-page":"21153","DOI":"10.1021\/acsnano.3c05005","volume":"17","author":"ZC Hu","year":"2023","unstructured":"Hu ZC, Wang B, Zhou XG, Liang HF, Liang B, Lu HW, et al. Golgi apparatus-targeted photodynamic therapy for enhancing tumor immunogenicity by eliciting NLRP3 protein-dependent pyroptosis. ACS Nano. 2023;17(21):21153\u201369.","journal-title":"ACS Nano"},{"issue":"4","key":"2416_CR88","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/0008-5472.CAN-24-1173","volume":"85","author":"J Nie","year":"2025","unstructured":"Nie J, Zhang S, Guo Y, Liu C, Shi J, Wu H, et al. Mapping of the T-cell landscape of biliary tract cancer unravels anatomic subtype-specific heterogeneity. Cancer Res. 2025;85(4):704\u201322.","journal-title":"Cancer Res"},{"issue":"4","key":"2416_CR89","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","volume":"72","author":"MA Martin-Serrano","year":"2023","unstructured":"Martin-Serrano MA, Kepecs B, Torres-Martin M, Bramel ER, Haber PK, Merritt E, et al. Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut. 2023;72(4):736\u201348.","journal-title":"Gut"},{"issue":"9","key":"2416_CR90","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349\u201369.","journal-title":"Cancer"},{"key":"2416_CR91","doi-asserted-by":"publisher","unstructured":"Hong L, Mei J, Sun X, Wu Y, Dong Z, Jin Y et al. Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma. Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001283.","DOI":"10.1097\/HEP.0000000000001283"},{"issue":"4","key":"2416_CR92","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ymthe.2025.02.019","volume":"33","author":"J Ruan","year":"2025","unstructured":"Ruan J, Li Q, Jin Y, Yin J, Ye C, Cheng F, et al. Multiple-omics analysis reveals a dedifferentiation-immune loop in intrahepatic cholangiocarcinoma. Mol Ther. 2025;33(4):1803\u201324.","journal-title":"Mol Ther"},{"issue":"2","key":"2416_CR93","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/cac2.12513","volume":"44","author":"W Liu","year":"2024","unstructured":"Liu W, Wang H, Zhao Q, Tao C, Qu W, Hou Y, et al. Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase \u03b1 (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. Cancer Commun. 2024;44(2):226\u201350.","journal-title":"Cancer Commun"},{"issue":"7","key":"2416_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412740","volume":"12","author":"L Zuyin","year":"2024","unstructured":"Zuyin L, Zhao L, Qian C, Changkun Z, Delin M, Jialing H, et al. Single-cell and spatial transcriptomics delineate the microstructure and immune landscape of intrahepatic cholangiocarcinoma in the leading-edge area. Adv Sci. 2024;12(7):e2412740.","journal-title":"Adv Sci"},{"issue":"11","key":"2416_CR95","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1158\/0008-5472.CAN-23-3298","volume":"84","author":"H Liao","year":"2024","unstructured":"Liao H, Chen X, Wang H, Lin Y, Chen L, Yuan K, et al. Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers. Cancer Res. 2024;84(11):1747\u201363.","journal-title":"Cancer Res"},{"issue":"1","key":"2416_CR96","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1038\/s41467-024-54387-8","volume":"15","author":"ZJ Zhou","year":"2024","unstructured":"Zhou ZJ, Ye YH, Hu ZQ, Hou YR, Liu KX, Sun RQ, et al. Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver. Nat Commun. 2024;15(1):9960.","journal-title":"Nat Commun"},{"key":"2416_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"issue":"10","key":"2416_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409173","volume":"12","author":"C Guan","year":"2025","unstructured":"Guan C, Gao J, Zou X, Shi W, Hao Y, Ge Y, et al. A novel 167-amino acid protein encoded by CircPCSK6 inhibits intrahepatic cholangiocarcinoma progression via IKB\u03b1 ubiquitination. Adv Sci. 2025;12(10):e2409173.","journal-title":"Adv Sci"},{"issue":"5","key":"2416_CR99","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2023.11.302","volume":"166","author":"M Lewinska","year":"2024","unstructured":"Lewinska M, Zhuravleva E, Satriano L, Martinez MB, Bhatt DK, Oliveira D, et al. Fibroblast-Derived Lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma. Gastroenterology. 2024;166(5):886\u2013e9017.","journal-title":"Gastroenterology"},{"issue":"2","key":"2416_CR100","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.32317","volume":"77","author":"Y Shiode","year":"2023","unstructured":"Shiode Y, Kodama T, Shigeno S, Murai K, Tanaka S, Newberg JY, et al. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-\u03baB-inducing kinase-mediated hepatocyte transdifferentiation. Hepatology. 2023;77(2):395\u2013410.","journal-title":"Hepatology"},{"issue":"1","key":"2416_CR101","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1038\/s41467-024-47514-y","volume":"15","author":"Y Zhen","year":"2024","unstructured":"Zhen Y, Liu K, Shi L, Shah S, Xu Q, Ellis H, et al. Fgfr inhibition blocks NF-\u0138B-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. Nat Commun. 2024;15(1):3805.","journal-title":"Nat Commun"},{"issue":"3","key":"2416_CR102","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","volume":"108","author":"CM McKee","year":"2020","unstructured":"McKee CM, Coll RC. Nlrp3 inflammasome priming: a riddle wrapped in a mystery inside an enigma. J Leukoc Biol. 2020;108(3):937\u201352.","journal-title":"J Leukoc Biol"},{"issue":"8","key":"2416_CR103","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2416_CR104","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48(4):331\u201344.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"2416_CR105","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.molmed.2020.06.005","volume":"26","author":"M Rashidi","year":"2020","unstructured":"Rashidi M, Wicks IP, Vince JE. Inflammasomes and cell death: common pathways in microparticle diseases. Trends Mol Med. 2020;26(11):1003\u201320.","journal-title":"Trends Mol Med"},{"issue":"9","key":"2416_CR106","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","volume":"11","author":"B Bai","year":"2020","unstructured":"Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11(9):776.","journal-title":"Cell Death Dis"},{"issue":"Pt 2","key":"2416_CR107","doi-asserted-by":"publisher","first-page":"113399","DOI":"10.1016\/j.intimp.2024.113399","volume":"143","author":"T Zhang","year":"2024","unstructured":"Zhang T, Zhu LX, Sun QK, Chen LJ, Qian YB. CARD9 promotes cholangiocarcinoma by regulating the IL-17A\/Hedgehog and the THEM4\/AKT\/mTOR signaling pathways. Int Immunopharmacol. 2024;143(Pt 2):113399.","journal-title":"Int Immunopharmacol"},{"key":"2416_CR108","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev-biochem-082411-113907","volume":"83","author":"CA Worby","year":"2014","unstructured":"Worby CA, Dixon JE. PTEN. Annu Rev Biochem. 2014;83:641\u201369.","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"2416_CR109","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2022.11.025","volume":"164","author":"TY Jiang","year":"2023","unstructured":"Jiang TY, Shi YY, Cui XW, Pan YF, Lin YK, Feng XF, et al. Pten deficiency facilitates exosome secretion and metastasis in cholangiocarcinoma by impairing TFEB-mediated lysosome biogenesis. Gastroenterology. 2023;164(3):424\u201338.","journal-title":"Gastroenterology"},{"issue":"1","key":"2416_CR110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-023-02699-w","volume":"42","author":"W Liao","year":"2023","unstructured":"Liao W, Du J, Li L, Wu X, Chen X, Feng Q, et al. CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN\/AKT pathway in intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2023;42(1):125.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2416_CR111","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhep.2024.02.018","volume":"81","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang J, Wan J, Cheng Q, Cheng Z, Zhou X, et al. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via Aurora kinase A in mice. J Hepatol. 2024;81(1):120\u201334.","journal-title":"J Hepatol"},{"issue":"6","key":"2416_CR112","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41556-020-0510-3","volume":"22","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wang H, Hao Y, Lin H, Dong M, Ye J, et al. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nat Cell Biol. 2020;22(6):716\u201327.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2416_CR113","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375(12):1161\u201370.","journal-title":"N Engl J Med"},{"issue":"12","key":"2416_CR114","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","volume":"13","author":"SI Ilyas","year":"2015","unstructured":"Ilyas SI, Eaton JE, Gores GJ. Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management. Clin Gastroenterol Hepatol. 2015;13(12):2152\u201365.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2416_CR115","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000360791","volume":"89","author":"S Rizvi","year":"2014","unstructured":"Rizvi S, Gores GJ. Current diagnostic and management options in perihilar cholangiocarcinoma. Digestion. 2014;89(3):216\u201324.","journal-title":"Digestion"},{"issue":"6","key":"2416_CR116","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045\u201355.","journal-title":"Hepatology"},{"issue":"2","key":"2416_CR117","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ajpath.2016.10.010","volume":"187","author":"L Maroni","year":"2017","unstructured":"Maroni L, Agostinelli L, Saccomanno S, Pinto C, Giordano DM, Rychlicki C, et al. Nlrp3 activation induces Il-18 synthesis and affects the epithelial barrier function in reactive cholangiocytes. Am J Pathol. 2017;187(2):366\u201376.","journal-title":"Am J Pathol"},{"issue":"3","key":"2416_CR118","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1073\/pnas.1322731111","volume":"111","author":"H Nakagawa","year":"2014","unstructured":"Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, et al. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci U S A. 2014;111(3):1090\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2416_CR119","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jgh.12711","volume":"30","author":"H Matsushita","year":"2015","unstructured":"Matsushita H, Miyake Y, Takaki A, Yasunaka T, Koike K, Ikeda F, et al. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics. J Gastroenterol Hepatol. 2015;30(3):600\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2416_CR120","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ajpath.2024.11.004","volume":"195","author":"N Wu","year":"2025","unstructured":"Wu N, Bayatpour S, Hylemon PB, Aseem SO, Brindley PJ, Zhou H. Gut microbiome and bile acid interactions: mechanistic implications for cholangiocarcinoma development, immune resistance, and therapy. Am J Pathol. 2025;195(3):397\u2013408.","journal-title":"Am J Pathol"},{"issue":"11","key":"2416_CR121","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1111\/liv.16069","volume":"44","author":"K Xu","year":"2024","unstructured":"Xu K, Kessler A, Nichetti F, Hoffmeister-Wittmann P, Scherr AL, Nader L, et al. Lymphotoxin beta-activated LTBR\/NIK\/RELB axis drives proliferation in cholangiocarcinoma. Liver Int. 2024;44(11):2950\u201363.","journal-title":"Liver Int"},{"key":"2416_CR122","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","volume":"70","author":"J Qu","year":"2019","unstructured":"Qu J, Yuan Z, Wang G, Wang X, Li K. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. Int Immunopharmacol. 2019;70:147\u201355.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2416_CR123","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","volume":"25","author":"H Hao","year":"2017","unstructured":"Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, et al. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies Cholestasis-Associated sepsis. Cell Metab. 2017;25(4):856\u2013e675.","journal-title":"Cell Metab"},{"issue":"4","key":"2416_CR124","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcmgh.2019.12.008","volume":"9","author":"SY Cai","year":"2020","unstructured":"Cai SY, Ge M, Mennone A, Hoque R, Ouyang X, Boyer JL. Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol Gastroenterol Hepatol. 2020;9(4):679\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"2416_CR125","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir I, McGuinness C, Poh AR, Ernst M, Darcy PK, Britt KL. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol. 2023;44(12):971\u201385.","journal-title":"Trends Immunol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02416-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T04:02:00Z","timestamp":1759377720000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02416-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}